The DOI matches its Crossref record; 238 of the 238 references it cites were found in a registry or an index.
Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence?
Open accessAbstract
Together with aspartate, glutamate is the major excitatory neurotransmitter in the brain. Glutamate binds and activates both ligand-gated ion channels (ionotropic glutamate receptors) and a class of G-protein coupled receptors (metabotropic glutamate receptors). Although the intracellular glutamate concentration in the brain is in the millimolar range, the extracellular glutamate concentration is kept in the low micromolar range by the action of excitatory amino acid transporters that import glutamate and aspartate into astrocytes and neurons. Excess extracellular glutamate may lead to excitotoxicity in vitro and in vivo in acute insults like ischemic stroke via the overactivation of ionotropic glutamate receptors. In addition, chronic excitotoxicity has been hypothesized to play a role in numerous neurodegenerative diseases including amyotrophic lateral sclerosis, Alzheimer's disease and Huntington's disease. Based on this hypothesis, a good deal of effort has been devoted to develop and test drugs that either inhibit glutamate receptors or decrease extracellular glutamate. In this review, we provide an overview of the different pathways that are thought to lead to an over-activation of the glutamatergic system and glutamate toxicity in neurodegeneration. In addition, we summarize the available experimental evidence for glutamate toxicity in animal models of neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Pathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Cell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
Glycine potentiates the NMDA response in cultured mouse brain neurons
Johnson, J. W., & Ascher, P. (1987) · Nature · doi:10.1038/325529a0 · Cited by 3,139
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Choi, D. W. (1992) · Journal of Neurobiology · doi:10.1002/neu.480230915 · Cited by 2,314
Glutamate: A Neurotransmitter in Mammalian Brain
Fonnum, F. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb09689.x · Cited by 1,992
Excitatory amino acid neurotoxicity and neurodegenerative disease
Meldrum, B., & Garthwaite, J. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90184-a · Cited by 1,771
Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1
Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., et al. (1997) · Science · doi:10.1126/science.276.5319.1699 · Cited by 1,752
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686 · cited 2×
“An influential study using primary neuronal cultures (Hardingham et al., 2002) suggested that synaptic and extrasynaptic NMDA receptors have counteracting effects on cell fate with nerve cell death being mainly mediated by extrasynaptic NMDA receptors.”
BackgroundResultMattson, M., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., & Rydel, R. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-02-00376.1992 · Cited by 1,627
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., et al. (2005) · Nature · doi:10.1038/nature03180 · Cited by 1,518 · cited 5×
“Cef is perhaps the best studied of these compounds and has been tested in models of AD (Zumkehr et al., 2015), HD (Miller et al., 2008), and ALS (Rothstein et al., 2005) with positive results.”
BackgroundInfluentialAging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,440
Requirement for Glycine in Activation of NMDA-Receptors Expressed in Xenopus Oocytes
Kleckner, N. W., & Dingledine, R. (1988) · Science · doi:10.1126/science.2841759 · Cited by 1,422
Long-term potentiation depends on release of d-serine from astrocytes
Henneberger, C., Papouin, T., Oliet, S. H. R., & Rusakov, D. A. (2010) · Nature · doi:10.1038/nature08673 · Cited by 1,389 · cited 1×
“Long-term potentiation depends on D-serine release from astrocytes in hippocampal slices, indicating that this amino acid indeed plays an important role in glutamatergic neurotransmission via NMDA receptors (Henneberger et al., 2010).”
BackgroundReplication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J., & Martin, J. B. (1986) · Nature · doi:10.1038/321168a0 · Cited by 1,286
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280 · cited 1×
“…strongly suggest that vesicular release from astrocytes plays a minor role, as the Ca+2-mediated release of L-glu was still present in astrocytes derived from dominant-negative SNARE mice (Wang et al., 2013) where vesicular release can be blocked by doxycycline withdrawal (Pascual et al., 2005).”
BackgroundQuinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263
Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea
COYLE, J. T., & SCHWARCZ, R. (1976) · Nature · doi:10.1038/263244a0 · Cited by 1,248
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
Rothstein, J. D., Martin, L. J., & Kuncl, R. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262204 · Cited by 1,177
Sato, H., Tamba, M., Ishii, T., & Bannai, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11455 · Cited by 1,109
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R. G., Mitchell, J. D., & Moore, D. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447.pub3 · Cited by 1,058
Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex
Arriza, J., Fairman, W., Wadiche, J., Murdoch, G., Kavanaugh, M., & Amara, S. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05559.1994 · Cited by 993
Glutamate as a neurotransmitter in the healthy brain
Zhou, Y., & Danbolt, N. C. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1180-8 · Cited by 979
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R., Mitchell, J., Lyon, M., & Moore, D. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447 · Cited by 909
Guam Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Linked to a Plant Excitant Neurotoxin
Spencer, P. S., Nunn, P. B., Hugon, J., Ludolph, A. C., Ross, S. M., Roy, D. N., & Robertson, R. C. (1987) · Science · doi:10.1126/science.3603037 · Cited by 897
NMDA receptor subunits: function and pharmacology
PAOLETTI, P., & NEYTON, J. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.08.011 · Cited by 887
Flux coupling in a neuronal glutamate transporter
Zerangue, N., & Kavanaugh, M. P. (1996) · Nature · doi:10.1038/383634a0 · Cited by 846
Howland, D. S., Liu, J., She, Y., Goad, B., Maragakis, N. J., Kim, B., Erickson, J., Kulik, J., DeVito, L., Psaltis, G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032539299 · Cited by 841
Schell, M. J., Molliver, M. E., & Snyder, S. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.9.3948 · Cited by 832
Chaudhry, F. A., Lehre, K. P., Lookeren Campagne, M. V., Ottersen, O. P., Danbolt, N. C., & Storm-Mathisen, J. (1995) · Neuron · doi:10.1016/0896-6273(95)90158-2 · Cited by 826
Mitochondrial Dysfunction in Neurodegenerative Diseases
Johri, A., & Beal, M. F. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192138 · Cited by 806 · cited 1×
“First, although compromised mitochondrial function has been repeatedly described in several neurodegenerative diseases (reviewed in Johri and Beal, 2012), the resulting impairments in energy supply are not nearly as severe as the energy failure in ischemic stroke.”
BackgroundOxidative Stress in Neurodegenerative Diseases
Niedzielska, E., Smaga, I., Gawlik, M., Moniczewski, A., Stankowicz, P., Pera, J., & Filip, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9337-5 · Cited by 800
Blood–Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism
Fukui, S., Schwarcz, R., Rapoport, S. I., Takada, Y., & Smith, Q. R. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb03460.x · Cited by 761
Synaptic and Extrasynaptic NMDA Receptors Are Gated by Different Endogenous Coagonists
Papouin, T., Ladépêche, L., Ruel, J., Sacchi, S., Labasque, M., Hanini, M., Groc, L., Pollegioni, L., Mothet, J.-P., & Oliet, S. H. R. (2012) · Cell · doi:10.1016/j.cell.2012.06.029 · Cited by 754
Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse
Baker, D. A., McFarland, K., Lake, R. W., Shen, H., Tang, X.-C., Toda, S., & Kalivas, P. W. (2003) · Nature Neuroscience · doi:10.1038/nn1069 · Cited by 739
Lin, C.-L. G., Bristol, L. A., Jin, L., Dykes-Hoberg, M., Crawford, T., Clawson, L., & Rothstein, J. D. (1998) · Neuron · doi:10.1016/s0896-6273(00)80997-6 · Cited by 671
Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain
Ingelsson, M., Fukumoto, H., Newell, K. L., Growdon, J. H., Hedley–Whyte, E. T., Frosch, M. P., Albert, M. S., Hyman, B. T., & Irizarry, M. C. (2004) · Neurology · doi:10.1212/01.wnl.0000115115.98960.37 · Cited by 666
Patneau, D., & Mayer, M. (1990) · The Journal of Neuroscience · doi:10.1523/jneurosci.10-07-02385.1990 · Cited by 653
Kynurenines in the CNS: recent advances and new questions
Vécsei, L., Szalárdy, L., Fülöp, F., & Toldi, J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3793 · Cited by 641 · cited 2×
“Additional endogenous small molecules that are thought to interfere with L-glu signaling are several intermediates of tryptophan metabolism (Vécsei et al., 2013; Figure 2).”
BackgroundAbnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis
Rothstein, J. D., Tsai, G., Kuncl, R. W., Clawson, L., Cornblath, D. R., Drachman, D. B., Pestronk, A., Stauch, B. L., & Coyle, J. T. (1990) · Annals of Neurology · doi:10.1002/ana.410280106 · Cited by 636
Apoptosis and Oxidative Stress in Neurodegenerative Diseases
Radi, E., Formichi, P., Battisti, C., & Federico, A. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-132738 · Cited by 630
Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.
Rothstein, J. D., Jin, L., Dykes-Hoberg, M., & Kuncl, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6591 · Cited by 623
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
Talantova, M., Sanz-Blasco, S., Zhang, X., Xia, P., Akhtar, M. W., Okamoto, S.-I., Dziewczapolski, G., Nakamura, T., Cao, G., Pratt, A. E., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1306832110 · Cited by 600
Zeron, M. M., Hansson, O., Chen, N., Wellington, C. L., Leavitt, B. R., Brundin, P., Hayden, M. R., & Raymond, L. A. (2002) · Neuron · doi:10.1016/s0896-6273(02)00615-3 · Cited by 595
Sheldon, A. L., & Robinson, M. B. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.03.012 · Cited by 594
The Origin and Neuronal Function of In Vivo Nonsynaptic Glutamate
Baker, D. A., Xi, Z.-X., Shen, H., Swanson, C. J., & Kalivas, P. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09134.2002 · Cited by 584
Manipulation of Brain Kynurenines: Glial Targets, Neuronal Effects, and Clinical Opportunities
Schwarcz, R., & Pellicciari, R. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.034439 · Cited by 556
The glutamate antagonist MK‐801 reduces focal ischemic brain damage in the rat
Park, C. K., Nehls, D. G., Graham, D. I., Teasdale, G. M., & McCulloch, J. (1988) · Annals of Neurology · doi:10.1002/ana.410240411 · Cited by 539
Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity
Hardingham, G. E., Arnold, F. J. L., & Bading, H. (2001) · Nature Neuroscience · doi:10.1038/85109 · Cited by 536
Glutamate Released from Glial Cells Synchronizes Neuronal Activity in the Hippocampus
Angulo, M. C., Kozlov, A. S., Charpak, S., & Audinat, E. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0473-04.2004 · Cited by 533
Purification of serine racemase: Biosynthesis of the neuromodulator d -serine
Wolosker, H., Sheth, K. N., Takahashi, M., Mothet, J.-P., Brady, R. O., Ferris, C. D., & Snyder, S. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.721 · Cited by 524
Milnerwood, A. J., Gladding, C. M., Pouladi, M. A., Kaufman, A. M., Hines, R. M., Boyd, J. D., Ko, R. W. Y., Vasuta, O. C., Graham, R. K., Hayden, M. R., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.008 · Cited by 517
Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
Zwilling, D., Huang, S.-Y., Sathyasaikumar, K. V., Notarangelo, F. M., Guidetti, P., Wu, H.-Q., Lee, J., Truong, J., Andrews-Zwilling, Y., Hsieh, E. W., et al. (2011) · Cell · doi:10.1016/j.cell.2011.05.020 · Cited by 515
The chemical excitation of spinal neurones by certain acidic amino acids
Curtis, D. R., Phillis, J. W., & Watkins, J. C. (1960) · The Journal of Physiology · doi:10.1113/jphysiol.1960.sp006410 · Cited by 498
The role of glutamate in epilepsy and other CNS disorders.
Meldrum, B. S. (1994) · PubMed · Cited by 479
Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity
Shin, J.-Y., Fang, Z.-H., Yu, Z.-X., Wang, C.-E., Li, S.-H., & Li, X.-J. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200508072 · Cited by 477
The presence of free D‐serine in rat brain
Hashimoto, A., Nishikawa, T., Hayashi, T., Fujii, N., Harada, K., Oka, T., & Takahashi, K. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80397-y · Cited by 462
Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis
Vucic, S., Nicholson, G. A., & Kiernan, M. C. (2008) · Brain · doi:10.1093/brain/awn071 · Cited by 460
Mothet, J.-P., Pollegioni, L., Ouanounou, G., Martineau, M., Fossier, P., & Baux, G. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408483102 · Cited by 460
Motor Neurons Are Selectively Vulnerable to AMPA/Kainate Receptor-Mediated InjuryIn Vitro
Carriedo, S. G., Yin, H. Z., & Weiss, J. H. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-13-04069.1996 · Cited by 441
Foster, A. C., Vezzani, A., French, E. D., & Schwarcz, R. (1984) · Neuroscience Letters · doi:10.1016/0304-3940(84)90050-8 · Cited by 434
Neuronal Exosomal miRNA-dependent Translational Regulation of Astroglial Glutamate Transporter GLT1
Morel, L., Regan, M., Higashimori, H., Ng, S. K., Esau, C., Vidensky, S., Rothstein, J., & Yang, Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.410944 · Cited by 430
Patterns of Status Epilepticus-Induced Neuronal Injury during Development and Long-Term Consequences
Sankar, R., Shin, D. H., Liu, H., Mazarati, A., Pereira de Vasconcelos, A., & Wasterlain, C. G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08382.1998 · Cited by 414
Motor discoordination and increased susceptibility to cerebellar injury in GLAST mutant mice
Watase, K., Hashimoto, K., Kano, M., Yamada, K., Watanabe, M., Inoue, Y., Okuyama, S., Sakagawa, T., Ogawa, S., Kawashima, N., et al. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00108.x · Cited by 409
Ceftriaxone Restores Glutamate Homeostasis and Prevents Relapse to Cocaine Seeking
Knackstedt, L. A., Melendez, R. I., & Kalivas, P. W. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.018 · Cited by 397
Kim, K., Lee, S., Kegelman, T. P., Su, Z., Das, S. K., Dash, R., Dasgupta, S., Barral, P. M., Hedvat, M., Diaz, P., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22609 · Cited by 395
Luján, R., Roberts, J. D. B., Shigemoto, R., Ohishi, H., & Somogyi, P. (1997) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(97)00051-3 · Cited by 395
Xia, P., Chen, H.-S. V., Zhang, D., & Lipton, S. A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2488-10.2010 · Cited by 379
Levine, M. S., Klapstein, G. J., Koppel, A., Gruen, E., Cepeda, C., Vargas, M. E., Jokel, E. S., Carpenter, E. M., Zanjani, H., Hurst, R. S., et al. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19991115)58:4<515::aid-jnr5>3.0.co;2-f · Cited by 352
LI, S., MALLORY, M., ALFORD, M., TANAKA, S., & MASLIAH, E. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199708000-00008 · Cited by 343
GABA and Glutamate Transporters in Brain
Zhou, Y., & Danbolt, N. C. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00165 · Cited by 343
Indoleamine 2,3 dioxygenase and quinolinic acid Immunoreactivity in Alzheimer's disease hippocampus
Guillemin, G. J., Brew, B. J., Noonan, C. E., Takikawa, O., & Cullen, K. M. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00655.x · Cited by 330
Behrens, P. F. (2002) · Brain · doi:10.1093/brain/awf180 · Cited by 320
NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum
Landwehrmeyer, G., Standaert, D., Testa, C., Penney, J., & Young, A. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-07-05297.1995 · Cited by 317
Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice
Liévens, J.-C., Woodman, B., Mahal, A., Spasic-Boscovic, O., Samuel, D., Kerkerian-Le Goff, L., & Bates, G. P. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0430 · Cited by 313
Miyamoto, E. (2006) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cpj06007x · Cited by 302
Ganong, A. H., Lanthorn, T. H., & Cotman, C. W. (1983) · Brain Research · doi:10.1016/0006-8993(83)91108-3 · Cited by 302
Petr, G. T., Sun, Y., Frederick, N. M., Zhou, Y., Dhamne, S. C., Hameed, M. Q., Miranda, C., Bedoya, E. A., Fischer, K. D., Armsen, W., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4255-14.2015 · Cited by 297 · cited 2×
“EAATs that play an important role in the uptake of vesicularly released L-glu in the CNS (Tanaka et al., 1997; Petr et al., 2015) also avidly take up L-asp (Arriza et al., 1994).”
BackgroundSun, Y., Savanenin, A., Reddy, P. H., & Liu, Y. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103501200 · Cited by 297
Astrocytic regulation of glutamate homeostasis in epilepsy
Coulter, D. A., & Eid, T. (2012) · Glia · doi:10.1002/glia.22341 · Cited by 290
Guo, H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg267 · Cited by 284
Miller, B. R., Dorner, J. L., Shou, M., Sari, Y., Barton, S. J., Sengelaub, D. R., Kennedy, R. T., & Rebec, G. V. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.02.004 · Cited by 280 · cited 1×
“Cef is perhaps the best studied of these compounds and has been tested in models of AD (Zumkehr et al., 2015), HD (Miller et al., 2008), and ALS (Rothstein et al., 2005) with positive results.”
BackgroundSlow, E. J., Graham, R. K., Osmand, A. P., Devon, R. S., Lu, G., Deng, Y., Pearson, J., Vaid, K., Bissada, N., Wetzel, R., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503634102 · Cited by 275
Glutamate as a Neurotransmitter
(2018) · Glutamine and Glutamate in Mammals · doi:10.1201/9781351072281-2 · Cited by 265
D‐Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis
Sasabe, J., Chiba, T., Yamada, M., Okamoto, K., Nishimoto, I., Matsuoka, M., & Aiso, S. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601840 · Cited by 265
Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease
GUIDETTI, P., LUTHICARTER, R., AUGOOD, S., & SCHWARCZ, R. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.006 · Cited by 260
Hashimoto, A., Kumashiro, S., Nishikawa, T., Oka, T., Takahashi, K., Mito, T., Takashima, S., Doi, N., Mizutani, Y., Yamazaki, T., et al. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03575.x · Cited by 256
β-N-methylamino-l-alanine enhances neurotoxicity through multiple mechanisms
Lobner, D., Piana, P. M. T., Salous, A. K., & Peoples, R. W. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.10.002 · Cited by 255
Presynaptic kynurenate‐sensitive receptors inhibit glutamate release
Carpenedo, R., Pittaluga, A., Cozzi, A., Attucci, S., Galli, A., Raiteri, M., & Moroni, F. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01592.x · Cited by 254
Oxidative Glutamate Toxicity Can Be a Component of the Excitotoxicity Cascade
Schubert, D., & Piasecki, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07455.2001 · Cited by 253
Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase
Mitchell, J., Paul, P., Chen, H.-J., Morris, A., Payling, M., Falchi, M., Habgood, J., Panoutsou, S., Winkler, S., Tisato, V., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914128107 · Cited by 249
VGLUTs: ‘Exciting’ times for glutamatergic research?
Takamori, S. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.04.016 · Cited by 249
Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease
Bogdanov, M. B., Andreassen, O. A., Dedeoglu, A., Ferrante, R. J., & Beal, M. F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00689.x · Cited by 248
The transsulfuration pathway: a source of cysteine for glutathione in astrocytes
McBean, G. J. (2012) · Amino Acids · doi:10.1007/s00726-011-0864-8 · Cited by 244
Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease
Overk, C. R., & Masliah, E. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.01.015 · Cited by 242 · cited 1×
“…via glycogen synthase kinase-3 beta or mitogen-activated protein kinases, cell cycle re-enty (reviewed by Majd et al., 2015), oxidative stress (reviewed by Niedzielska et al., 2015), or decreased transport of trophic factors and mitochondrial dysregulation (reviewed by Overk and Masliah, 2014).”
BackgroundStehberg, J., Moraga‐Amaro, R., Salazar, C., Becerra, A., Echeverría, C., Orellana, J. A., Bultynck, G., Ponsaerts, R., Leybaert, L., Simon, F., et al. (2012) · The FASEB Journal · doi:10.1096/fj.11-198416 · Cited by 238
Kynurenine metabolism in Alzheimer's disease
Baran, H., Jellinger, K., & Deecke, L. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050149 · Cited by 236
Rosenberg, D., Artoul, S., Segal, A. C., Kolodney, G., Radzishevsky, I., Dikopoltsev, E., Foltyn, V. N., Inoue, R., Mori, H., Billard, J.-M., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3836-12.2013 · Cited by 233
ARZBERGER, T., KRAMPFL, K., LEIMGRUBER, S., & WEINDL, A. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199704000-00013 · Cited by 232
Arginine Conversion to Nitroxide by Tetrahydrobiopterin-free Neuronal Nitric-oxide Synthase
Adak, S., Wang, Q., & Stuehr, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004337200 · Cited by 229
Inciting Excitotoxic Cytocide Among Central Neurons
Olney, J. W. (1986) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4684-7971-3_48 · Cited by 229
Hansson, O., Petersén, Å., Leist, M., Nicotera, P., Castilho, R. F., & Brundin, P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8727 · Cited by 228 · cited 1×
“…was only observed in the transgenic YAC model of HD (Zeron et al., 2002), whereas mice over-expressing mutant htt exon 1, R6/1 and R6/2 mice, (Hansson et al., 1999, 2001b) or N171-82Q mice over-expressing mutant exon 1 and parts of exon 2 (Jarabek et al., 2004) or the so-called “shortstop”…”
BackgroundOrganization of NMDA receptors at extrasynaptic locations
Petralia, R. S., Wang, Y. X., Hua, F., Yi, Z., Zhou, A., Ge, L., Stephenson, F. A., & Wenthold, R. J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.022 · Cited by 227
PGC-1α, mitochondrial dysfunction, and Huntington's disease
Johri, A., Chandra, A., & Flint Beal, M. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.016 · Cited by 221
Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex
Flint Beal, M., Matson, W. R., Storey, E., Milbury, P., Ryan, E. A., Ogawa, T., & Bird, E. D. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90191-m · Cited by 218
d -Amino acid oxidase controls motoneuron degeneration through d -serine
Sasabe, J., Miyoshi, Y., Suzuki, M., Mita, M., Konno, R., Matsuoka, M., Hamase, K., & Aiso, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114639109 · Cited by 213
Dzubay, J. A., & Jahr, C. E. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-13-05265.1999 · Cited by 213 · cited 1×
“In the cerebellum, it was demonstrated by analyzing AMPA receptor-mediated currents in Bergmann glia that synaptically released L-glu concentrations can reach extrasynaptic concentrations of up to 190µM, while concentrations in the synaptic cleft exceed 1mM (Dzubay and Jahr, 1999).”
BackgroundDebono, M.-W., Le Guern, J., Canton, T., Doble, A., & Pradier, L. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90147-a · Cited by 210
Extrasynaptic and synaptic NMDA receptors form stable and uniform pools in rat hippocampal slices
Harris, A. Z., & Pettit, D. L. (2007) · The Journal of Physiology · doi:10.1113/jphysiol.2007.137679 · Cited by 202
Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease
Scott, H. A., Gebhardt, F. M., Mitrovic, A. D., Vandenberg, R. J., & Dodd, P. R. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.008 · Cited by 202
Zhou, X., Hollern, D., Liao, J., Andrechek, E., & Wang, H. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.82 · Cited by 200
Mutant Huntingtin Enhances Excitotoxic Cell Death
Zeron, M. M., Chen, N., Moshaver, A., Ting-Chun Lee, A., Wellington, C. L., Hayden, M. R., & Raymond, L. A. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0909 · Cited by 197
Bendotti, C., Tortarolo, M., Suchak, S. K., Calvaresi, N., Carvelli, L., Bastone, A., Rizzi, M., Rattray, M., & Mennini, T. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00572.x · Cited by 195
Tong, J., Huang, C., Bi, F., Wu, Q., Huang, B., Liu, X., Li, F., Zhou, H., & Xia, X. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.122 · Cited by 195
De Bundel, D., Schallier, A., Loyens, E., Fernando, R., Miyashita, H., Van Liefferinge, J., Vermoesen, K., Bannai, S., Sato, H., Michotte, Y., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5465-10.2011 · Cited by 193
Quinn, C. T., Griener, J. C., Bottiglieri, T., Hyland, K., Farrow, A., & Kamen, B. A. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2800 · Cited by 189
Mitani, A., & Tanaka, K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-07176.2003 · Cited by 189
Amyloid-β 1–42 Slows Clearance of Synaptically Released Glutamate by Mislocalizing Astrocytic GLT-1
Scimemi, A., Meabon, J. S., Woltjer, R. L., Sullivan, J. M., Diamond, J. S., & Cook, D. G. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.5274-12.2013 · Cited by 185
Identification of quinolinic acid in rat and human brain tissue
Wolfensberger, M., Amsler, U., Cuénod, M., Foster, A. C., Whetsell, W. O., & Schwarcz, R. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90458-5 · Cited by 185
3‐Hydroxykynurenine potentiates quinolinate but not NMDA toxicity in the rat striatum
Guidetti, P., & Schwarcz, R. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00806.x · Cited by 180
Subtype‐Specific Enhancement of NMDA Receptor Currents by Mutant Huntingtin
Chen, N., Luo, T., Wellington, C., Metzler, M., McCutcheon, K., Hayden, M. R., & Raymond, L. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0721890.x · Cited by 180
SYNTHESIS AND METABOLISM OF l‐KYNURENINE IN RAT BRAIN
Gál, E. M., & Sherman, A. D. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb07815.x · Cited by 177
Riluzole increases high-affinity glutamate uptake in rat spinal cord synaptosomes
Azbill, R. D., Mu, X., & Springer, J. E. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02430-6 · Cited by 175
Lewerenz, J., Albrecht, P., Tien, M. T., Henke, N., Karumbayaram, S., Kornblum, H. I., Wiedau‐Pazos, M., Schubert, D., Maher, P., & Methner, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06347.x · Cited by 175
Self-citationKynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus.
Ganong, A. H., & Cotman, C. W. (1986) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38782-3 · Cited by 172
Organization, control and function of extrasynaptic NMDA receptors
Papouin, T., & Oliet, S. H. R. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0601 · Cited by 171
Takahashi, K., Kong, Q., Lin, Y., Stouffer, N., Schulte, D. A., Lai, L., Liu, Q., Chang, L., Dominguez, S., Xing, X., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20140413 · Cited by 169
Zumkehr, J., Rodríguez‐Ortiz, C. J., Cheng, D., Kieu, Z., Wai, T., Hawkins, C., Kilian, J., Lim, S., Medeiros, R., & Kitazawa, M. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.005 · Cited by 167
Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice
Guidetti, P., Bates, G. P., Graham, R. K., Hayden, M. R., Leavitt, B. R., MacDonald, M. E., Slow, E. J., Wheeler, V. C., Woodman, B., & Schwarcz, R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.011 · Cited by 166
Hansson, O., Guatteo, E., Mercuri, N. B., Bernardi, G., Li, X., Castilho, R. F., & Brundin, P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01767.x · Cited by 165
Patel, S. A., Warren, B. A., Rhoderick, J. F., & Bridges, R. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.08.006 · Cited by 164
GLT-1 Loss Accelerates Cognitive Deficit Onset in an Alzheimer's Disease Animal Model
Mookherjee, P., Green, P. S., Watson, G. S., Marques, M. A., Tanaka, K., Meeker, K. D., Meabon, J. S., Li, N., Zhu, P., Olson, V. G., et al. (2011) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2011-110503 · Cited by 163
Amyotrophic lateral sclerosis: Amino acid levels in plasma and cerebrospinal fluid
Perry, T. L., Krieger, C., Hansen, S., & Eisen, A. (1990) · Annals of Neurology · doi:10.1002/ana.410280105 · Cited by 163
Animal models of BMAA neurotoxicity: A critical review
Karamyan, V. T., & Speth, R. C. (2008) · Life Sciences · doi:10.1016/j.lfs.2007.11.020 · Cited by 161
Changes in extracellular amino acid neurotransmitters produced by focal cerebral ischemia
Graham, S. H., Shiraishi, K., Panter, S. S., Simon, R. P., & Faden, A. I. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90799-f · Cited by 160
Role of oxidative DNA damage in mitochondrial dysfunction and Huntington’s disease pathogenesis
Ayala‐Peña, S. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.04.017 · Cited by 159
Lodge, D. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.006 · Cited by 158
Palaiologos, G., Hertz, L., & Schousboe, A. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb04872.x · Cited by 158
Bail, M. L., Martineau, M., Sacchi, S., Yatsenko, N., Radzishevsky, I. S., Conrod, S., Ouares, K. A., Wolosker, H., Pollegioni, L., Billard, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416668112 · Cited by 158
Berdichevsky, E., Riveros, N., Sánchez‐Armass, S., & Orrego, F. (1983) · Neuroscience Letters · doi:10.1016/0304-3940(83)90489-5 · Cited by 157
Small-molecule activator of glutamate transporter EAAT2 translation provides neuroprotection
Kong, Q., Chang, L.-C., Takahashi, K., Liu, Q., Schulte, D. A., Lai, L., Ibabao, B., Lin, Y., Stouffer, N., Mukhopadhyay, C. D., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci66163 · Cited by 156
Cerebrospinal fluid levels of transition metals in patients with Parkinson's disease
Jiménez‐Jiménez, F. J., Molina, J. A., Aguilar, M. V., Meseguer, I., Mateos-Vega, C. J., González‐Muñoz, M. J., de Bustos, F., Martínez‐Salio, A., Pareja, M. O., Zurdo, M., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050073 · Cited by 153
The Activation of Metabotropic Glutamate Receptors Protects Nerve Cells from Oxidative Stress
Sagara, Y., & Schubert, D. A. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-17-06662.1998 · Cited by 151
Facilitation of Spinal NMDA Receptor Currents by Spillover of Synaptically Released Glycine
Ahmadi, S., Muth‐Selbach, U., Lauterbach, A., Lipfert, P., Neuhuber, W., & Zeilhofer, H. U. (2003) · Science · doi:10.1126/science.1083970 · Cited by 144
The kynurenine pathway and inflammation in amyotrophic lateral sclerosis
Chen, Y., Stankovic, R., Cullen, K. M., Meininger, V., Garner, B., Coggan, S., Grant, R., Brew, B. J., & Guillemin, G. J. (2010) · Neurotoxicity Research · doi:10.1007/s12640-009-9129-7 · Cited by 141 · cited 1×
“Independently, it was described that tryptophan and KYN levels are increased in the CSF from ALS patients as compared to controls (Chen et al., 2010).”
BackgroundAβ1-42 induces production of quinolinic acid by human macrophages and microglia
Guillemin, G. J., Smythe, G. A., Veas, L. A., Takikawa, O., & Brew, B. J. (2003) · Neuroreport · doi:10.1097/00001756-200312190-00005 · Cited by 141
Liu, X., Rush, T., Zapata, J. Y., & Lobner, D. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.002 · Cited by 141
Gundersen, V., Chaudhry, F. A., Bjaalie, J. G., Fonnum, F., Ottersen, O. P., & Storm‐Mathisen, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-16-06059.1998 · Cited by 137
Shehadeh, J., Fernandes, H. B., Mullins, M. Z., Graham, R. K., Leavitt, B. R., Hayden, M. R., & Raymond, L. A. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.001 · Cited by 136
Qin, S., Colin, C., Hinners, I., Gervais, A., Cheret, C., & Mallat, M. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5186-05.2006 · Cited by 135 · cited 2×
“In vitro, Aβ induces L-glu release from primary microglia via upregulation of system x−c (Qin et al., 2006).”
BackgroundDo, K., Herrling, P., Streit, P., Turski, W. A., & Cuénod, M. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02226.1986 · Cited by 131
Bannai, S., & Ishii, T. (1982) · Journal of Cellular Physiology · doi:10.1002/jcp.1041120216 · Cited by 131
Zeng, L., Ouyang, Y., Gazit, V. A., Cirrito, J. R., Jansen, L. A., Ess, K. C., Yamada, K. A., Wozniak, D. F., Holtzman, D. M., Gutmann, D. H., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.015 · Cited by 131
Meléndez, R. I., Vuthiganon, J., & Kalivas, P. W. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.081521 · Cited by 129
Estrada‐Sánchez, A. M., Montiel, T., Segovia, J., & Massieu, L. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.12.017 · Cited by 127
Massie, A., Schallier, A., Kim, S. W., Fernando, R. N., Kobayashi, S., Beck, H., Bundel, D. D., Vermoesen, K., Bannai, S., Smolders, I. J., et al. (2010) · The FASEB Journal · doi:10.1096/fj.10-177212 · Cited by 126
Glutamate and other CSF amino acids in Alzheimer's disease
Pomara, N., Singh, R., Deptula, D., Chou, J., Schwartz, M. B., & LeWitt, P. A. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.2.251 · Cited by 126
Loss of the astrocyte glutamate transporter GLT1 modifies disease in SOD1G93A mice
Pardo, A. C., Wong, V., Benson, L. M., Dykes, M., Tanaka, K., Rothstein, J. D., & Maragakis, N. J. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.03.028 · Cited by 125
System xc−Activity and Astrocytes Are Necessary for Interleukin-1β-Mediated Hypoxic Neuronal Injury
Fogal, B., Li, J., Lobner, D., McCullough, L. D., & Hewett, S. J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.2459-07.2007 · Cited by 123
Mesci, P., Zaïdi, S., Lobsiger, C. S., Millecamps, S., Escartin, C., Seilhean, D., Sato, H., Mallat, M., & Boillée, S. (2014) · Brain · doi:10.1093/brain/awu312 · Cited by 119
Fan, J., Cowan, C. M., Zhang, L. Y. J., Hayden, M. R., & Raymond, L. A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.2491-09.2009 · Cited by 117
Huang, K., Kang, M. H., Askew, C. E., Kang, R., Sanders, S. S., Wan, J., Davis, N. G., & Hayden, M. R. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.027 · Cited by 116
Ikonomidou, C., Qin, Y., Labruyere, J., & Olney, J. W. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199602000-00010 · Cited by 115
Moroni, F., Russi, P., Carlà, V., & Lombardi, G. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90285-6 · Cited by 113
Bengtson, C. P., & Bading, H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-3-7091-0932-8_17 · Cited by 112
Massie, A., Boillée, S., Hewett, S. J., Knackstedt, L. A., & Lewerenz, J. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13348 · Cited by 111
Self-citationSchallier, A., Smolders, I., Van Dam, D., Loyens, E., De Deyn, P. P., Michotte, A., Michotte, Y., & Massie, A. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-101005 · Cited by 109 · cited 3×
“Semiquantitative immunoblot analysis revealed an upregulation of xCT protein expression in the frontal cortex in aged AβPP23 mice compared to wild-type controls (Schallier et al., 2011).”
BackgroundInfluentialGanel, R., Ho, T. W., Maragakis, N. J., Jackson, M. T., Steiner, J. P., & Rothstein, J. D. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.014 · Cited by 109
Basun, H., Forssell, L. G., Almkvist, O., Cowburn, R. F., Eklöf, R., Winblad, B. G., & Wetterberg, L. (1990) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02252924 · Cited by 109
Sasaki, S., Komori, T., & Iwata, M. (2000) · Acta Neuropathologica · doi:10.1007/s004019900159 · Cited by 108
Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease
Jiménez‐Jiménez, F. J., Molina, J. A., Gómez, P. A., Vargas, C., de Bustos, F., Benito‐León, J., Tallón-Barranco, A., Pareja, M. O., Gasalla, T., & Arenas, J. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050056 · Cited by 106
Excitatory Amino Acid Receptor Potency and Subclass Specificity of Sulfur‐Containing Amino Acids
Pullan, L. M., Olney, J. W., Price, M. T., Compton, R. P., Hood, W. F., Michel, J., & Monahan, J. B. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb10024.x · Cited by 105
Shi, Q., Savage, J. E., Hufeisen, S. J., Rauser, L., Grajkowska, E., Ernsberger, P. R., Wroblewski, J. T., Nadeau, J. H., & Roth, B. L. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.047092 · Cited by 104
Glutamate, a neurotransmitter—And so much more
Hertz, L. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.021 · Cited by 102
Vargas‐Caballero, M., & Robinson, H. P. C. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1380-04.2004 · Cited by 101
Beckstrøm, H., Julsrud, L., Haugeto, Ø., Dewar, D., Graham, D. I., Lehre, K. P., Storm‐Mathisen, J., & Danbolt, N. C. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990115)55:2<218::aid-jnr9>3.0.co;2-l · Cited by 97
Genetic Heterogeneity in Alzheimer Disease and Implications for Treatment Strategies
Dominantly Inherited Alzheimer Network, Ringman, J. M., Goate, A., Masters, C. L., Cairns, N. J., Danek, A., Graff-Radford, N., Ghetti, B., & Morris, J. C. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0499-8 · Cited by 96 · cited 1×
“Hereditary forms of AD are caused by mutations in the Aβ precursor protein, AβPP, or in the presenilins, which are part of the multi-protein complex involved in Aβ generation (Ringman et al., 2014).”
BackgroundCalcium dysregulation links ALS defective proteins and motor neuron selective vulnerability
Leal, S. S., & Gomes, C. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00225 · Cited by 96
Fan, J., Gladding, C. M., Wang, L., Zhang, L. Y. J., Kaufman, A. M., Milnerwood, A. J., & Raymond, L. A. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.019 · Cited by 96
Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington's mouse model
Jarabek, B. R., Yasuda, R. P., & Wolfe, B. B. (2003) · Brain · doi:10.1093/brain/awh058 · Cited by 96
Colton, C. K., Kong, Q., Lai, L., Zhu, M. X., Seyb, K. I., Cuny, G. D., Xian, J., Glicksman, M. A., & Lin, C.-L. (2010) · SLAS DISCOVERY · doi:10.1177/1087057110370998 · Cited by 95
Excitatory Amino Acid Neurotoxicity
Gillessen, T., Budd, S. L., & Lipton, S. A. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0123-7_1 · Cited by 91
The IDO Inhibitor Coptisine Ameliorates Cognitive Impairment in a Mouse Model of Alzheimer's Disease
Yu, D., Tao, B.-B., Yang, Y.-Y., Du, L., Yang, S.-S., He, X.-J., Zhu, Y., Yan, J., & Yang, Q. (2014) · Journal of Alzheimer's Disease · doi:10.3233/jad-140414 · Cited by 88
Majd, S., Power, J. H. T., & Grantham, H. J. M. (2015) · BMC Neuroscience · doi:10.1186/s12868-015-0211-1 · Cited by 88
Clinical Aspects of CAG Repeat Diseases
Nance, M. (1997) · Brain Pathology · doi:10.1111/j.1750-3639.1997.tb00892.x · Cited by 88
Bao, X., Pal, R., Hascup, K. N., Wang, Y., Wang, W., Xu, W., Hui, D., Aǵbaş, A., Wang, X., Michaelis, M. L., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4413-09.2009 · Cited by 82
Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis
Iłżecka, J., Kocki, T., Stelmasiak, Z., & Turski, W. A. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00076.x · Cited by 82
Kalbaugh, T. L., Zhang, J., & Diamond, J. S. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4240-08.2009 · Cited by 80
Gianfriddo, M., Melani, A., Turchi, D., Giovannini, M. G., & Pedata, F. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.05.008 · Cited by 77
Palmini, R. B., Masi, A., Narducci, R., Cavone, L., Maratea, D., Cozzi, A., Sili, M., Moroni, F., & Mannaioni, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082180 · Cited by 77
Martı́nez, M., Frank, A., Díez‐Tejedor, E., & Hernánz, Á. (1993) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02252617 · Cited by 77
Baran, H., & Schwarcz, R. M. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04553.x · Cited by 75
Wang, F., Smith, N., Xu, Q., Goldman, S., Peng, W., Huang, J. H., Takano, T., & Nedergaard, M. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2178-13.2013 · Cited by 75
Domoic acid: Neurobehavioral consequences of exposure to a prevalent marine biotoxin
Grant, K. S., Burbacher, T. M., Faustman, E. M., & Grattan, L. M. (2009) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2009.09.005 · Cited by 74
The Glutamatergic Neurotransmission in the Central Nervous System
Marmiroli, P., & Cavaletti, G. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799462711 · Cited by 73
Cited by
Dysregulation of brain and choroid plexus cell types in severe COVID-19
Yang, A. C., Kern, F., Losada, P. M., Agam, M. R., Maat, C. A., Schmartz, G. P., Fehlmann, T., Stein, J. A., Schaum, N., Lee, D. P., et al. (2021) · Nature · doi:10.1038/s41586-021-03710-0 · Cited by 620
Inflammation, glutamate, and glia: a trio of trouble in mood disorders
Haroon, E., Miller, A. H., & Sanacora, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.199 · Cited by 584
The role of zinc, copper, manganese and iron in neurodegenerative diseases
Mezzaroba, L., Alfieri, D. F., Colado Simão, A. N., & Vissoci Reiche, E. M. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.07.007 · Cited by 524
Costa, L. G., Cole, T. B., Dao, K., Chang, Y.-C., Coburn, J., & Garrick, J. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107523 · Cited by 484
Tagge, C. A., Fisher, A. M., Minaeva, O. V., Gaudreau-Balderrama, A., Moncaster, J. A., Zhang, X.-L., Wojnarowicz, M. W., Casey, N., Lu, H., Kokiko-Cochran, O. N., et al. (2018) · Brain · doi:10.1093/brain/awx350 · Cited by 383
Metadata
- Authors
- Lewerenz, J., & Maher, P.
- Venue
- Frontiers in Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2015-12-16
- Volume
- 9
- Pages
- 469-469
- ISSN
- 1662-453X (ISSN-L)
- OpenAlex
- W2212369426
- Cited by
- 718
- References
- 238
- FWCI
- 18.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.